ARTICLE | Clinical News
Lurbinectedin: Phase Ib data
June 22, 2015 7:00 AM UTC
Data from 21 evaluable patients with small cell lung cancer (SCLC) who failed 1 prior chemotherapy-containing regimen in an open-label, dose-escalation, dose-expansion, European Phase Ib trial showed ...